We have ambitious future plans for the growth of our business as well as for the benefit..
Our Vision is to provide world class, cost-effective products for the international as well as domestic market reuirement..
We have constructed a modernized infrastructure unit to maintain smooth functioning of business activities.
Ever since our organization has been incepted, we have given utmost importance to the quality standards of the products.
WELCOME TO SHREYA LIFE SCIENCES
Shreya has strategic alliance with Bio Technology General Corporation, USA,
through SciGen, Singapore and Scitech USA to import and market Recombinant Human
Insulin, Hepatitis B Vaccine & Growth Hormone (BTGC acquired by Ferring).
License agreement with Bioton, Poland, to import Recombinant Human Insulin Crystals and finished formulation of Recombinant Human Insulin Cartridges through SciGen.
License agreement with Biotech GmBH, Germany (BBT) to market Gonadotropins in India.
License agreement with Generex Biotechnology Corporation, Canada / USA to distribute and market Oral Recosulin, 'Oral-Lyn' on an exclusive basis in Indian sub-continent which includes India, Nepal, Pakistan, Bhutan, Bangladesh, Srilanka & Myanmar .
Licence agreement with Lallemand and Institute Rosell, France, to market Probiotics.